Here's Why Ipsen S.A. Just Paid €700M For Memo Therapeutics AG

🇺🇸 Seeking Alpha (US) —
Here's Why Ipsen S.A. Just Paid €700M For Memo Therapeutics AG

AI Summary

Ipsen S.A. acquired Memo Therapeutics AG for €700 million, marking a significant investment in the biotech sector. This deal is part of Ipsen's strategic expansion in innovative therapeutic areas.

Markets Deals Health Ipsen S.A. Memo Therapeutics AG acquisition biotech investment therapeutics

Read original source →